Linda Dwoshin

Title: Linda Dwoshin: Innovator in CNS Pathology Treatment

Introduction

Linda Dwoshin is a notable inventor based in Lexington, KY (US). She has made significant contributions to the field of neuroscience through her innovative research and patent work. Her focus on developing compounds for treating various central nervous system (CNS) pathologies has positioned her as a key figure in medical research.

Latest Patents

Linda Dwoshin holds a patent for "Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies." This patent addresses the treatment of addiction to nicotinic receptor agonists, psychostimulant drugs, opiates, alcohol, tobacco products, and nicotine. Additionally, it targets conditions such as schizophrenia, depression, Alzheimer's disease, Parkinson's disease, irritable bowel syndrome, and colitis. The compounds she developed competitively inhibit CNS acting nicotinic receptor agonists and act at the putative α3β2* and α4β2 neuronal nicotinic receptors in the central nervous system. She has 1 patent to her name.

Career Highlights

Linda is affiliated with the University of Kentucky Research Foundation, where she conducts her research. Her work has been instrumental in advancing the understanding and treatment of CNS-related disorders.

Collaborations

Some of her notable coworkers include Joshua T Ayers and Peter Anthony Crooks. Their collaborative efforts have contributed to the success of her research initiatives.

Conclusion

Linda Dwoshin's innovative work in developing compounds for CNS pathologies showcases her dedication to improving treatment options for various addictions and mental health conditions. Her contributions to the field are invaluable and continue to inspire future research.